The question of deterring/avoiding prostate cancer brings this report to Malegard.
One thing we know about prostate cancer is this: not one new case of prostate cancer has initiated in men taking Malegard™ starting as early as 1998.

The Malegard 2010 Study updates prostate information and provides the following five(5)-point approach to prostate health including a special review of antigen.

1. Coping with prostate cancer 2010:
   1.6 million biopsies found
   217,000 new prostate cancers.
   Prostate cancer killed 32,500 U.S men.
2. Antigen manufactured by your prostate flows almost unceasingly, unseen and unfelt, into your organs. There it generates anti-bodies. These are the proteins your body normally uses to overcome invaders attacking your health. The problem is that if you have no invaders to attack, anti-bodies attack healthful organs and tissues.
3. Antibodies produced by antigen are the main actors in the development of prostatitis.
4. Prostate growth is the primary source of BPH and its resultant distress.
5. Men taking Malegard report significant health benefits.
   

Strict principles of research require us to answer that question: no.

At least not yet, although men’s experience taking Malegard beginning 1998 is a long time to determine what Malegard can do to maintain prostate health.

We leave it up to you to review the results of our 2010 study and judge how they relate to you. Not just that men taking Malegard did not initiate prostate cancer during the 13 years 1998 to 2010. But also what Malegard has done, and is doing, for men struggling with BPH/excessive urination.

PSA results reported by 54 men taking Malegard for 13 consecutive years 1998-2010

(Group 1 of 2 groups).

That handful of numbers totally fails to suggest that those results in the 54 “Malegard men” is rare in the extreme. The following prostate cancer averages and Malegard’s “zero results” should help to recognize the significance of what took place from 1998 through 2010.

For results of another 88 men taking Malegard 2003-2010 see the separate table in Part 2.

PSAs reported by 54 men taking Malegard 1998 - 2010
PSAs in bold went down or did not increase, indicating minimum to no cancer risk
PSAs in brackets increased less than 0.35ng/ml/year, indicating no cancer risk.

FIND YOUR PSA

During the years no prostate cancer was found in these 54 men, they were under treatment for 5 other, life-endangering diseases:

For results of another 88 men taking Malegard 2003-2010 see the separate table in Part 2.

PSA’s reported by men taking Malegard 2003 through 2110

See separate table in Part I for results of men taking Malegard 1998 - 2010
Bold PSAs: went down or did not increase: minimum cancer risks in near future
Red PSAs: free of prostate cancer risk with 0.35ng/ml increase or less per year
(See separate table for men taking Malegard 1998-2002)

Urination (BPH) problems are one of the most common, and aggravating ailments in aging men. Therefore improvement in these problems is extremely significant:

More significant than improvement in urination, in terms of improving men’s health, is another Malegard finding. While 36 of 54 men in this part of the 2010 Report reported urination benefits in varying degrees from taking Malegard, another 16 men taking Malegard stated they were taking nothing else to improve their urination health.

Your Health Threat Triplet:
Antigen, “Silent” Inflammation, and Prostate Cancer

The start of this 2010 Malegard report briefly summarized the way antigen produced by your prostate enters your bloodstream and flows into your organs. In your organs it generates your body’s inflammatory defense against invaders -- antibodies. As antibodies destroy such invaders as viruses, bacteria and fungi attacking your health, their defensive inflammation is essential to protect your life.
After recognizing antigen’s defense against attacks to your health, men need to
consider how it can turn into your enemy – in fact, one of the worst enemies to your health you can face.

How does this threat to male health and life take place?
The answer couldn’t be simpler.

When your immune system has no anti-bodies to destroy, it loses its original purpose. Then it can begin to destroy healthy cells, especially cellular DNA. Harvard University researchers who discovered this condition of attack-destruction named it “silent inflammation.”
Those inflammatory cells in your body may be “silent” -- unfelt and unnoticed -- but they are busily generating free radicals – toxic molecules that oxidize your DNA and cause genetic mutations.

Origin of prostate cancer
Mutations of oxidized DNA lead to the uncontrolled cell division that is a characteristic of prostate cancer.
What is the source of oxidized DNA? The answer is inflammation – unfortunately “silent.” Urologists at Johns Hopkins have found pockets of inflammation in the very heart of cancerous and other abnormal cells. Part of the areas of inflammation contained something new: clusters of cells that look as if dying but are actually dividing ---proliferating. What to make of this? The researchers think such abnormal cells are either a beginning of prostate cancer or a breeding ground for it. (Italics supplied.)

Deterring/avoiding prostate cancer
No one knows how many urologists, and how many drug companies, have searched for a preventive to prostate cancer. One of these efforts has found that of 90,000 men, those who took 6, yes 6, aspirin a day reduced their prostate cancer risks 24%. Taking “statin” and cholesterol medications also have an anti-inflammatory effect. But the end results of these studies have meant nothing really useful.

The question of deterring/avoiding prostate cancer brings this report to Malegard.
One thing we know about prostate cancer is this: not one case of prostate cancer has originated in men taking Malegard starting as early as 1998.

Malegard™ 12 year Survey results